Document is current
Any future updates will be listed below
-
Authors
Naderi, Nariman
Safavi-Naini, Seyed Amir Ahmad
Savage, Thomas
Khalafi, Mohammad Amin
Lewis, Peter R.
Atf, Zahra
Nadkarni, Girish
Soroush, Ali
-
Funding
Funding for this research was provided by:
American Gastroenterological Association (AGA2023-32-06)
- License Information
-
More Information
Article History
Received: 22 May 2025
Accepted: 7 January 2026
First Online: 5 February 2026
Competing interests
: The authors declare no competing financial interests or personal relationships that could have influenced the work reported in this study. N.N.: none; S.A.A.S.N.: none; T.S.: none; M.K.: none; P.L.: none; Z.A.: none; G.N.: is a founder of Renalytix, Pensieve, and Verici and provides consultancy services to AstraZeneca, Reata, Renalytix, and Pensieve. He also has equity in Renalytix, Pensieve, and Verici; A.S. is on the advisory board and has equity in Virgo Surgical Solutions.
